Safety and Efficacy of Carboxymethylcellulose for Ocular Surface Integrity in Symptomatic Dry Eye

PHASE4CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

July 31, 2010

Study Completion Date

September 30, 2010

Conditions
Dry Eye SyndromesKeratoconjunctivitis Sicca
Interventions
DRUG

carboxymethylcellulose 0.5% , glycerin 0.9% (OPTIVE® MD)

One drop in each eye three to six times daily, as needed

DRUG

sodium hyaluronate 0.18% (VISMED® Multi)

One drop in each eye three to six times daily, as needed

Trial Locations (1)

Unknown

Paris

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY

NCT00987727 - Safety and Efficacy of Carboxymethylcellulose for Ocular Surface Integrity in Symptomatic Dry Eye | Biotech Hunter | Biotech Hunter